BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4836611)

  • 1. Chloroquine-induced ocular toxicity.
    Petrohelos MA
    Ann Ophthalmol; 1974 Jun; 6(6):615-8. PubMed ID: 4836611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retinal disease due to chloroquine].
    François J; de Rouck A; Cambie E; de Laey JJ
    Bull Soc Belge Ophtalmol; 1972; 160(2):581-90. PubMed ID: 4656812
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ocular intoxication due to chloroquine and its derivatives. Importance of functional studies, ERG and EOG. Study of a series of 400 cases (1964-71)].
    Parizot H
    Bull Soc Belge Ophtalmol; 1972; 160(2):570-80. PubMed ID: 4656811
    [No Abstract]   [Full Text] [Related]  

  • 4. Chloroquine retinopathy.
    Easterbrook M
    Arch Ophthalmol; 1991 Oct; 109(10):1362. PubMed ID: 1929921
    [No Abstract]   [Full Text] [Related]  

  • 5. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF; Bhargava SK; Rosen ES
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C; Bechetoille A; Ebran JM
    J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular changes caused by long-lasting use of chloroquine and its derivatives in rheumatoid disease].
    Drewnowska-Sochańska A; Kuprianowicz W; Petrus B
    Klin Oczna; 1970; 40(4):499-503. PubMed ID: 5453064
    [No Abstract]   [Full Text] [Related]  

  • 8. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
    Ruiz RS; Saatci OA
    Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy.
    Bernstein HN
    Am J Med; 1983 Jul; 75(1A):25-34. PubMed ID: 6869408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmologic considerations in using antimalarials in the United States.
    Rynes RI
    Lupus; 1996 Jun; 5 Suppl 1():S73-4. PubMed ID: 8803917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.
    Finbloom DS; Silver K; Newsome DA; Gunkel R
    J Rheumatol; 1985 Aug; 12(4):692-4. PubMed ID: 4057189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for antimalarial toxicity.
    Easterbrook M
    Can J Ophthalmol; 1993 Apr; 28(2):51-2. PubMed ID: 8508335
    [No Abstract]   [Full Text] [Related]  

  • 14. Pigmentary skin changes associated with ocular chloroquine toxicity in Ghana.
    Bentsi-Enchill KO
    Trop Geogr Med; 1980 Sep; 32(3):216-20. PubMed ID: 7210154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term course of antimalarial maculopathy after cessation of treatment.
    Easterbrook M
    Can J Ophthalmol; 1992 Aug; 27(5):237-9. PubMed ID: 1393809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
    Bertrand JJ; Debeyre N; Kahn MF; Ryckewaert A
    Presse Med (1893); 1968 Nov; 76(45):2139-42. PubMed ID: 5720115
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1966; 44(3):335-48. PubMed ID: 5953229
    [No Abstract]   [Full Text] [Related]  

  • 18. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term course of chloroquine retinopathy after cessation of medication.
    Brinkley JR; Dubois EL; Ryan SJ
    Am J Ophthalmol; 1979 Jul; 88(1):1-11. PubMed ID: 463998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression.
    Hart WM; Burde RM; Johnston GP; Drews RC
    Arch Ophthalmol; 1984 Mar; 102(3):377-80. PubMed ID: 6703984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.